Our Products
Shire Canada and Shire Human Genetic Therapies (Canada) provide basic
information on our products as approved by Health Canada and in accordance
with federal regulations. Should you wish to obtain more information on a
product, please contact your healthcare professional. The information
provided in this section is intended for residents of Canada only.
|
Products |
Patient Information |
Public Advisory |
Product Monograph
December 2011 |
Consumer Information
December 2011
|
|
AGRYLIN® Product Monograph,
September 2011 |
AGRYLIN® Consumer Information,
September 2011 |
|
ALERTEC® Product Monograph,
Jan 2012 |
ALERTEC® Consumer Information,
Jan 2012 |
ALERTEC®
December 2007 public
advisory |
ELAPRASE® Product Monograph,
May 2008 |
ELAPRASE® Consumer Information,
May 2008 |
|
ESTRACE® Product Monograph,
October 2007 |
ESTRACE® Consumer Information,
October 2007 |
|
FOSRENOL® Product Monograph,
October 2010 |
FOSRENOL® Consumer Information,
October 2010 |
|
MEZAVANT® Product Monograph,
May 2011 |
MEZAVANT® Consumer Information,
May 2011 |
|
REPLAGAL® Product Monograph,
May 2008 |
REPLAGAL® Consumer Information,
May 2008 |
|
VPRIV® Product Monograph,
October 2010 | | |
VYVANSE® Product Monograph,
December 2011 |
VYVANSE® Consumer Information,
December 2011 |
|